Examining 30-day COPD readmissions through the emergency department

Area of Science:

• Pulmonary Medicine
• Healthcare Management
• Clinical Research

Background:

• Thirty-day readmission for Chronic Obstructive Pulmonary Disease (COPD) presents a significant clinical and economic burden.
• The emergency department (ED) is a critical point of contact for patients with COPD, offering potential for readmission reduction strategies.

Purpose of the Study:

• To investigate factors contributing to 30-day COPD readmissions via the ED.
• To identify specific patient subgroups within the COPD population who may benefit from targeted readmission reduction interventions.

Main Methods:

• Retrospective cohort study of 1,574 adult patients with COPD from January 2009 to September 2015.
• Analysis of electronic health record data to identify risk factors for ED readmission within 30 days of index COPD admission.
• Logistic regression modeling to assess the relationship between potential risk factors and readmission.

Main Results:

• Over 82% of patients presenting to the ED within 30 days of a COPD admission were readmitted.
• Key predictors of readmission included higher Charlson score, chief complaint of breathing difficulty, and specific outpatient medication use (albuterol, fluticasone/salmeterol, inhaled steroids, tiotropium).
• ED testing such as arterial blood gas and B-type natriuretic peptide also correlated with readmission.

Conclusions:

• Nearly all patients with COPD re-presenting to the ED within 30 days are readmitted, necessitating intensive outpatient monitoring and follow-up.
• Improved decision support and management strategies are crucial for patients presenting with breathing difficulties, particularly those with shorter index hospital stays (<48 hours).